Announcements Trials

Browse Landscape

Phase

Phase NA 6 Phase 3 1

Status

Completed 4 Active not recruiting 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pathologic Complete Response 1

Interventions

Paclitaxel 24 Oxaliplatin 24 Capecitabine 24 Gemcitabine 21 Cisplatin 21 Fluorouracil 20 Drug Therapy 18 Docetaxel 18 Carboplatin 17 pembrolizumab 15 Leucovorin 15 Irinotecan 15 Radiotherapy 12 tislelizumab 11 Magnetic Resonance Spectroscopy 10 Bevacizumab 10 Specimen Handling 9 Pemetrexed 9 Radiation 8 Injections 8 Cetuximab 8 toripalimab 7 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Azacitidine 7 venetoclax 6 sintilimab 6 Trastuzumab 6 Topotecan 6 Standard of Care 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Colonoscopy × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡